Autor: |
Piccinni A; Dipartimento di Medicina Clinica e Sperimentale - Section of Psychiatry University of Pisa Via Roma 67 Pisa 56126 Italy.; Fondazione BRF Onlus - Institute for Research in Psychiatry and Neuroscience Via Vecchia III 51 Lucca 55100 Italy., Veltri A; Dipartimento di Medicina Clinica e Sperimentale - Section of Psychiatry University of Pisa Via Roma 67 Pisa 56126 Italy.; Fondazione BRF Onlus - Institute for Research in Psychiatry and Neuroscience Via Vecchia III 51 Lucca 55100 Italy., Marazziti D; Dipartimento di Medicina Clinica e Sperimentale - Section of Psychiatry University of Pisa Via Roma 67 Pisa 56126 Italy.; Fondazione BRF Onlus - Institute for Research in Psychiatry and Neuroscience Via Vecchia III 51 Lucca 55100 Italy., Mucci F; Dipartimento di Medicina Clinica e Sperimentale - Section of Psychiatry University of Pisa Via Roma 67 Pisa 56126 Italy., Cozzi A; Fondazione BRF Onlus - Institute for Research in Psychiatry and Neuroscience Via Vecchia III 51 Lucca 55100 Italy.; IRSEA - Research Institute in Semiochemistry and Applied Ethology Quartier Salignan Apt 84400 France., Pageat P; Fondazione BRF Onlus - Institute for Research in Psychiatry and Neuroscience Via Vecchia III 51 Lucca 55100 Italy.; IRSEA - Research Institute in Semiochemistry and Applied Ethology Quartier Salignan Apt 84400 France. |
Jazyk: |
angličtina |
Zdroj: |
Clinical case reports [Clin Case Rep] 2018 Feb 23; Vol. 6 (4), pp. 664-668. Date of Electronic Publication: 2018 Feb 23 (Print Publication: 2018). |
DOI: |
10.1002/ccr3.1348 |
Abstrakt: |
This article is a case-report series showing the effectiveness of a three-month exposure to a synthetic analogue of Human Appeasing Pheromone as add-on strategy to psychopharmacological treatment on behavioral and residual symptoms of three patients suffering from severe psychiatric disorders with complex clinical pictures. |
Databáze: |
MEDLINE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|